The in vitro hypoglycemic effect of longan fruit (Dimocarpus longan var. Fen Ke) shell extracts was evaluated by inhibiting α-glucosidase and β-galactosidase activities. The IC 50 values of hot water and 50% ethanol ultrasonic extracts against the α-glucosidase were 9.2 and 13.4 mg/mL, and those against the β-galactosidase were 12.9 and 19.7 mg/mL, respectively. The hot water extracts (20 mg/mL) with aid of ultrasound-assisted extraction may enhance the inhibitory rates of α-glucosidase and β-galactosidase by 10.6 and 12.0% as compared with conventional extraction, respectively. Two phenolic compounds, gallic acid and ellagic acid, were identified as the major phenolic in hot water extracts from longan fruit shell against α-glucosidase and β-galactosidase. Inhibition of α-glucosidase and βgalactosidase were proven to be as a therapeutic approach for decreasing postprandial hyperglycemia. As a result, the longan fruit shell extracts may develop to be as a potential strategy for early treatment of postprandial hyperglycemia.
INTRODUCTION
Longan (Dimocarpus longan Lour.) belongs to the Sapindaceae family, which is a common fruit and is widely distributed in China, Taiwan, Thailand, and Vietnam. [1] Dimocarpus longan var. Fen Ke is the predominant species cultivated in Taiwan. Longan fruit shell (LFS) is commonly recognized as agricultural wastes in longan products processing, which may possibly contain multiple bioactive compounds, such as phenolic acids, flavonoids, and polysaccharide. Phenolic acids and flavonoids were proven to play a role in the functional component for displaying pharmacological activities, including antioxidant, anti-inflammatory, anticancer, and anti-tyrosinase effects. [2] [3] [4] Currently, phenolic compounds from natural plant may exhibit the inhibition against α-glucosidase and α-amylase was reported. [5] [6] [7] The results of this study illustrated that phenolic compounds in LFS may be a potential inhibitor of carbohydrate-hydrolyzing enzymes for a therapy of hypoglycemia.
Diabetes mellitus (DM) is a chronic disease in the disorder of carbohydrate metabolism and is characterized by hyperglycemia resulting from deficiencies in insulin secretion and/or insulin action. [8] The management of blood glucose levels is a critical role in the early treatment of DM through carbohydrate adsorption after dietary intake. [9] One of the therapeutic approaches for improving diabetes is to decrease postprandial blood glucose levels by inhibiting carbohydratehydrolyzing enzymes. [10, 11] The major source of glucose in the blood is due to hydrolysis of dietary starch, which is generated by the action of α-amylase and α-glucosidase involved in starch breakdown and intestinal absorption, respectively. [12] The inhibition of these key enzymes may significantly alleviate the postprandial increase of blood glucose levels, and cause an effective management of hyperglycemia linked to type 2 diabetes. [13] Human α-amylase is mainly secreted from the pancreas and salivary glands, which play an initial process in digestion of long chain carbohydrates such as starch and glycogen. α-Amylase is responsible for occasioning the production of shorter oligosaccharides from the cleavage of α-D-(1-4) glycosidic linkages of starch, glycogen, and various maltodextrins. [14, 15] The other enzyme, α-glucosidase, is located in the brush-border surface membrane of intestinal cells, and it makes a case of glucose liberation from the non-reducing end of the sugar. [12, 15] Inhibition of these enzymes may be recognized as an effective strategy in the administration of hyperglycemia. [16] Moreover, βgalactosidase is also a member of the glycosyl hydrolysis enzyme, which may cause the occurrence in releasing of glucose and galactose by way of the cleavage of β-1,4-D-galactosidic linkage of lactose. [17] This enzyme activates the final step in the process of carbohydrate digestion resulting in breakdown disaccharides and oligosaccharides into absorbable glucose. Therefore, the inhibitor of these hydrolytic enzymes may ameliorate postprandial hyperglycemia through restraining the influx of glucose from the intestinal tract to blood vessels.
Alleviation of the postprandial hyperglycemia by retarding glucose production is one of the therapeutic approaches for amelioration of diabetes. [7] α-glucosidase inhibitor was effectively applied to be as one of hypoglycemic drugs for amelioration of diabetes. The synthetic compounds, such as acarbose, miglitol, and voglibose, were widely used as clinical drugs for treatment of DM patients, acting by inhibiting α-amylase and α-glucosidase activity resulting in decreasing blood glucose levels. [10, 12] The synthetic inhibitors of α-glucosidase are proven to use as oral antidiabetic drugs for the therapy of type 2 DM, which may cause the undesirable side effects such as liver toxicity, diarrhea, and flatulence. [11, 12, 18] Phytochemical compounds had been verified to make the effect on the inhibition of α-glucosidase activity that is included catechin, theaflavin, quercetin, rutin, and chlorogenic acid. [19, 20] Development of natural inhibitor from plants may be a potential therapy for hyperglycemia resulting from potential alternative to synthetic inhibitors against α-glucosidase activity. Accordingly, the objective of this study is to investigate the effect of phenolic compound in LFS extracts on inhibition of α-glucosidase and βgalactosidase resulting in the improvement of hyperglycemia.
MATERIALS AND METHODS

Materials and Chemicals
There are three cultivars of longan fruit recognized as specimen for this study. Dimocarpus longan var. Fen Ke (DL1) is harvested in August and purchased from Zhongliao Township, Nantou County, Taiwan. Dimocarpus longan var. Shui Gong (DL2) is acquired in July and purchased from Dongshan District, Tainan City, Taiwan. Dimocarpus longan var. Shi Ya (DL3) is obtained in 
Conventional Extraction of LFS
The LFS were peeled, air-dried (40℃), and pulverized by a desktop pulverizer (RT-34, Chyun Tseh Industrial Co. Ltd., Taichung, Taiwan). The shell powder passing through 30-mesh stainless steel sieve was stored at 25℃ for further analysis. Ten grams of LFS powder were mixed with 500 mL of hot water (95℃) for 60 min and 500 mL of 50% ethanol for 24 h, respectively. After extraction, the extracted solution was filtered, and the filtrate was evaporated the solvent using a rotary evaporator. Finally, the freeze-dried extracts were obtained by lyophilizing in a freeze-dryer (EYELA FDU-1200, Rikakikai Co. Ltd., Tokyo, Japan) for further evaluation. The extract yields were calculated as the weight (g) from 10 g raw material and expressed in percentage on a dry basis.
Ultrasound-Assisted Extraction of LFS
The ultrasound-assisted extraction was carried out by the method of Yang et al. [21] with slight modifications. Ten grams of LFS powder were extracted by 500 mL of hot water (95℃) and 500 mL of 50% ethanol with the aid of ultrasonic cleaner (UC-5150B, Chrom Tech, Inc., Apple Valley, MN, USA) for 30 min, and then extracted without ultrasonic treatment up to 60 min and 24 h, respectively. The freeze-dried extracts were obtained by filtration, concentration, and lyophilization sequentially. The extract yields were calculated according to the method in agreement with conventional extraction.
Determination of Total Phenolic Content
Total phenolic contents of LFS extracts were determined by the method of Prasad et al. [3] with slight modification. In brief, the extracts dissolved in 50% ethanol were mixed with 2 mL of 2% Na 2 CO 3 solution and stand at room temperature. After 5 min, 0.1 mL of 50% Folin-Ciocalteu reagent was added and stood for 30 min at 25℃, and measured the absorbance using a spectrophotometer (GENESYS 10S UV, Thermo Fisher Scientific Inc., Madison, WI, USA) at 750 nm. The assay was performed in triplicates. The total phenolic contents were calculated by the calibration curve of gallic acid and expressed as μg gallic acid equivalents (GAE) per mg of extract (μg GAE/mg).
Effect of Extracts on Diffusion of Glucose in Starch-α-Amylase System
Inhibition of α-Amylase activity on diffusion of decreasing glucose by the extracts from LFS was determined according to the method of Ou et al. [22] with minor modifications. Potato starch (40 g) was added to 900 mL of 0.05 M phosphate buffer (pH 6.5) and stirred at 65°C for 30 min. The solution was made up to a final volume of 1000 mL to give a 4% (w/v) starch solution. The starchα-amylase system consisted of the potato starch solution, 0.4% (w/v) α-amylase, and 2.0% (w/v) extracts of LFS. Each of these solutions (25 mL) was dialyzed against 200 mL of deionized water at 37°C. The hexokinase assay kit was applied to determine glucose content in the dialysate at 10, 20, 30, 60, 90, 120, 150, 180, and 300 min. The assay was performed in triplicates.
Determination of α-Glucosidase Inhibitory Activity
Effect of LFS extracts on inhibition of α-glucosidase activity was evaluated using the method of Tan et al. [20] with some modifications. Yeast α-glucosidase dissolved in 0.1 M phosphate buffer (pH 6.8) was used as enzyme solution (0.2 U/mL, 100 μL). One hundred microliters of different concentrations of LFS extracts and 200 μL of 0.1 M phosphate buffer (pH 6.8) were added and then incubated at 37°C for 15 min. After pre-incubation, 100 μL of 2.5 mM PNPG solution in 0.1 M phosphate buffer (pH 6.8) was added and incubated at 37°C for 30 min. The reaction was concluded by adding 600 μL of 0.2 M sodium carbonate solution. The absorbance of the mixture solution was measured by a spectrophotometer at 405 nm, while the reaction system without αglucosidase was recognized as the control group. The assay was performed in triplicates. The enzyme inhibitory rates of LFS extracts were calculated according to the following equation:
Determination of β-Galactosidase Inhibitory Activity
The effect of LFS extracts on β-galactosidase activity was evaluated using the method from sigma product information with slight modification. β-galactosidase enzyme solution was adjusted to 0.2 U/mL by 0. 
Phenolic Compound Analysis by HPLC
Phenolic compounds from LFS extracts were identified using the HPLC method of Prasad et al. [4] and quantified by external standard method. Ten micrograms of LFS extract was dissolved in 1 mL of 50% ethanol and filtered by mini-membrane (0.45 μm). The samples were analyzed using an UV detector L-2400 (Hitachi High Technologies Corporation, Tokyo, Japan). The separation was performed using a Atlantis C18 column (Atlantis T3, 150 mm × 4.6 mm, 3 μm size particle, Waters, Milford, MA, USA), operated at 25°C. The samples were eluted with a mobile phases consist of 0.5% acetic acid acid (A) and methanol (B) by the flow rates of 1 mL/min. The injection volume of sample liquid was 10 μL. The gradient system started from 0 min (100% A) to 2 min (95% A), 5 min (70% A), 10 min (66% A), 20 min (50% A), 25 min (45% A), 30 min (0% A), and 42 min (100% A) and maintained at this ratio for 10 min. The peaks of the phenolic compounds were detected at 270 nm. Phenolic compound such as gallic acid, ellagic acid, and rutin were used as the standard for comparison. The identified phenolic compounds were quantified on the basis of their peak area and compared with a calibration curve obtained with the corresponding standards and then expressed as mg/g dry weight (DW).
Statistical Analysis
Data obtained from triplicate experiments are presented as the mean ± standard deviation. Statistical significance was analyzed by one-way analysis of variance (ANOVA) and Duncan's new multiple range tests. Results were considered statistically significant at p < 0.05.
RESULTS AND DISCUSSION
Evaluation of Hypoglycemic Effect Using in Vitro Dialysis Model
Hyperglycemia has been a classical risk in the development of diabetes and the complications associated with diabetes. Inhibition of the carbohydrate-hydrolyzing enzymes may be a feasible strategy for control of blood glucose levels. α-amylase is secreted by salivary glands and pancreas, which is a key enzyme and responsible for the decomposition of starch and glycogen into glucose. This hydrolytic enzyme plays a predominant role in the occurrence of the processing of starch degradation. [23, 24] Starch-α-amylase in vitro dialysis model was employed in this study to evaluate the effect of LFS extracts on suppressing α-amylase activity. The dialysate with lower glucose levels as contrasted with the control group represented inhibition of α-amylase activity. [22] In this study, the dialysis model was recognized as a method for sieving out the one with optimum effect on inhibition of α-amylase activity from three species of LFS extracts. The results indicated that 95℃ hot water and 50% ethanoic extracts from the shell of Dimocarpus longan var. Fen Ke (DL1), Dimocarpus longan var. Shui Gong (DL2), and Dimocarpus longan var. Shi Ya (DL3) may significantly diminish glucose levels in dialysate. The effect of hot water extracts on inhibition of glucose liberation is superior to that of ethanoic extracts universally. The water and 50% ethanoic extracts from the shell of DL3 displayed preferable effect on decrease of glucose levels by inhibition of α-amylase activity at different times (Fig. 1) . The respective inhibitory rate of the water and ethanoic extracts of DL3 is 49.2 and 41.3% at 300 min, which have better effect as compared with other two species of LFS ( Fig. 1) . Kim et al. [25] indicated that herbal extracts rich in polyphenols may restrain the activity of αamylase. The previous study revealed that LFS extracts are abundant in phenolic compounds. The extracts from the shell of DL3 with optimum effect on α-amylase inhibitory may be the occasion of higher phenolic content in comparison with DL1 and DL2 (data not shown). The extracts from natural plants with α-amylase inhibitory activity had been recognized a potent approach of therapy for alleviating postprandial hyperglycemia of type 2 DM. [11, 12] Jo et al. [26] reported that water extract of Omija (Schizandra chinensis) fruit may make a case of in vitro anti-hyperglycemic effect against α-amylase activity. We speculated that α-amylase activity may be repressed by the phenolic compounds in the extracts of LFS resulting in anti-hyperglycemia as a consequence.
Effect of Ultrasound-Assisted Extraction on Extraction Yield and Total Phenolic Content of the Shell from Dimocarpus Longan var. Fen Ke (DL1)
The results of α-amylase inhibitory assay revealed that the extracts from the shell of Dimocarpus longan var. Shi Ya (DL3) exhibited superior inhibition. The effect of the shell from Dimocarpus Longan var. Fen Ke (DL1) on suppressing α-amylase activity is inferior to that of DL3. Nevertheless, DL1 with the excellent yield is the predominant cultivar of longan cultivated in Taiwan. Therefore, DL1 was recognized as a candidate to proceed with ultrasound-assisted extraction according to the above mentioned inference. The results indicated that the ultrasonic treatment made a cause of increment in the extraction yield of water and ethanol extraction, from 19.5 to 23.3% and from 14.8 to 17.9%, respectively ( Table 1 ). The total phenolic content of water and ethanol extracts may be Table 1 ). The enhancement in extraction yield and total phenolic content of the shell from DL1 via ultrasoundassisted extraction is thus proved. Rodrigues and Pinto [27] had demonstrated that ultrasound assisted extraction technology may significantly increase the contents of total phenolic compounds in the extracts from coconut shell. Furthermore, the previous study indicated that the extraction rate and total phenolic contents in 50% ethanol extracts of LFS treated by ultra-high-pressure assisted extraction (500 Pa) is 2.4 and 2.0 times of conventional extraction. [3] The extraction of LFS accompanied additional assistance such as the treatment of ultrasonic wave and high pressure may be feasible to cause the occurrence of enhancement in the content of phenolic compounds by a basis of above mentioned results.
Evaluation of Longan Fruit (DL1) Shell Extracts on α-Glucosidase and β-Galactosidase Inhibitory
The longan fruit (DL1) shell was selected to be the specimen in further study involved in αglucosidase and β-galactosidase inhibitory for evaluation of in vitro hypoglycemic properties. The hot water and 50% ethanol extraction were carried out by the aid of ultrasound-assisted extraction. The results revealed that hot water and 50% ethanol extracts from the shell of DL1 may cause a dose-dependent effect on increasing inhibitory rate of the two enzymes (Tables 2 and 3 ). The hot water extracts possess ascendant inhibitory activity against α-glucosidase and β-galactosidase as compared with 50% ethanol extracts, which may be correlated with higher phenolic contents. All data are represented as the mean ± SD of three replicates.Different letters in the same column indicate statistically difference at p< 0.05.WE: 95°C water extraction; WUE: 95°C water extraction with ultrasound-assisted treatment; EE: 50% ethanol extraction; EUE: 50% ethanol extraction with ultrasound-assisted treatment. All data are represented as the mean ± SD of three replicates. Different letters in the same column indicate statistical difference at p < 0.05.WE: 95°C water extraction; WUE: 95°C water extraction with ultrasound-assisted treatment; EE: 50% ethanol extraction; EUE: 50% ethanol extraction with ultrasound-assisted treatment.
Moreover, the treatment of ultrasonic wave may cause a modification in the effect of α-glucosidase and β-galactosidase inhibitory. Table 2 showed that the assistance of ultrasonic wave in hot water extraction significantly increased α-glucosidase inhibitory rate of 20 mg/mL extracts by 10.6% of the conventional extracts ( Table 2 ). The IC 50 value of α-glucosidase for hot water extracts (20 mg/ mL) was declined from 11.9 mg/mL in conventional extraction to 9.2 mg/mL in ultrasound-assisted extraction ( Table 2 ). The extracts (20 mg/mL) of ultrasonic hot water extraction improved βgalactosidase inhibitory by 12.0% as compared with the conventional extracts ( Table 3 ). The IC 50 value of β-galactosidase for ultrasonic hot water extracts (20 mg/mL) was decreased from 16.2 mg/ mL in conventional extraction to 12.9 mg/mL in ultrasound-assisted extraction ( Table 3 ). The application of ultrasound-assisted extraction may improve the effect of water extracts from DL1 on the inhibition against α-glucosidase and β-galactosidase. In contrast, the ultrasound-assisted 50% ethanol extracts revealed no remarkable effects on improvement of the inhibitory rate of the enzymes. Veggi et al. [28] reported that ultrasonic extraction may considerably improve the quantitative extraction of phenolic compounds present in jatoba (Hymenaea courbaril L.var stilbocarpa) bark. We postulated that the increase of phenolic contents in LFS extracts by ultrasonic treatment may cause a result in enhancing the effects of α-glucosidase and β-galactosidase inhibitory as the consequence.
Inhibition of α-glucosidase and β-galactosidase may reduce the release of glucose and monosaccharide from carbohydrate after a meal, which play a potential role in controlling blood sugar levels bringing about anti-hyperglycemia. [11, 15, 29] The synthetic inhibitors of α-glucosidase, acarbose and voglibose, are commonly used as oral antidiabetic drugs for a therapy in type 2 DM, which may cause the occurrence of undesirable side effects. [10] [11] [12] Phenolic compounds from natural plants and agricultural crops were proven to display an important role in modulating αglucosidase activities resulting in the management of type 2 DM. [10, 20, [29] [30] [31] [32] Recently, the natural α-glucosidase and β-galactosidase inhibitors from the dietary plants with minimal side effects may be an effective strategy for alleviating postprandial hyperglycemia. For example, Chaenomeles sinensis fruit extracts were recognized as potent natural source for the treatment of type 2 diabetes by suppressing α-glucosidase and β-galactosidase activities. [29] The water extracts from Ascophyllum nodosum were proved to exhibit anti-hyperglycemic effect by inhibiting α-glucosidase activity because of abundant phenolic compounds. [32] Five flavonols and two phenolic acids isolated from Gynura medica leaf extracts displayed powerful α-glucosidase inhibitory against diabetes in vitro. [20] Chu et al. [10] demonstrated that four phytochemicals, including epicatechin (EC), epicatechin-(4β,8)-epicatechin gallate (B2-3′-O-gallate), epicatechin gallate (ECG), and 2-(4hydroxyphenyl) ethyl 3,4,5-trihydroxybenzoate (HETB) isolated from Rhodiola crenulata were identified as α-glucosidase inhibitor for reducing postprandial plasma glucose levels. The results of this study indicated that DL1 extracts displayed potent inhibitory against α-glucosidase and All data are represented as the mean ± SD of three replicates. Different letters in the same column indicate statistical difference at p < 0.05.WE: 95°C water extraction; WUE: 95°C water extraction with ultrasound-assisted treatment; EE: 50% ethanol extraction; EUE: 50% ethanol extraction with ultrasound-assisted treatment.
IN VITRO HYPOGLYCEMIC ACTIVITY OF LONGAN FRUIT SHELL
β-galactosidase. Therefore, we comprehended that LFS may be potential α-glucosidase and β-glucosidase inhibitor for management diabetes via effectively decreasing the release of glucose.
Identification of Polyphenolic Compounds by HPLC Assay
Ultrasonic hot water extracts had superior effect on inhibiting α-glucosidase and β-galactosidase activities by comparison with ethanol extracts. Therefore, phenolic compounds in ultrasonic hot water extracts from longan fruit (DL1) shell were distinguished by comparing the retention times with standards compound. The HPLC profile (Fig. 2) illustrated that two major phenolic compounds, gallic acid and ellagic acid, were identified and quantified through external standard method of Prasad et al. [3] with minor modification. The results from the present study was in agreement with that reported by Prasad et al. [3] , where gallic acid and ellagic acid were identified from LFS as the consequence. The contents of gallic acid and ellagic acid in DL1 were calculated by the calibration curves of the standards, which are 2.0 and 0.9 mg/g DW, respectively. Gallic acid is commonly used in the pharmaceutical industry that it is seems to have anti-oxidative, anti-carcinogenic, anti-allergic, anti-hyperglycemic, anti-antifungal, and anti-viral properties. [33] [34] [35] For instance, gallic acid was illustrated to enhance glucose uptake via inducing glucose transporter-4 (GLUT4) translocation in adipocytes and caused a result of in vitro hypoglycemic activity. [36] Gallic acid was also verified to ameliorate glucose metabolism by upregulation of peroxisome proliferator-activated receptors (PPARγ) expression and activation of Akt signaling pathway in diet-induced obesity mice resulting in anti-hyperglycemic activity. [35] Gallic acid in the extract from black gram (Vigna mungo L.) was proved to be a potent inhibitor for suppressing α-glucosidase enzyme. [37] Ahmed et al. [33] demonstrated that gallic acid caused noticeable inhibitory property against β-galactosidase, with 68% inhibition of activity at the concentration of 25 μM. Hypoglycemic properties of ellagic acid may be due to declining plasma glucose, blood glycosylated hemoglobin, and hexokinase activity and elevating plasma insulin and C-peptide, blood hemoglobin, glycogen (liver and muscle) in streptozotocin (STZ) induced diabetic rats. [38] Ellagic acid causes the maintenance of glucose homeostasis and may be recognized as a therapeutic agent in the management of DM was reported by Malini et al. [38] Moreover, ellagic acid had been found to exhibited antidiabetic properties via suppressing α-glucosidase activity. [6] Zhang et al. [39] reported that ellagic acid isolated from raspberries display an effective inhibitory against α-glucosidase activity resulting in limiting starch digestion for amelioration on postprandial hyperglycemia. Inhibition of αglucosidase and β-galactosidase activity may play a role in controlling blood sugar levels leading to a case of hypoglycemic property were reported by Nair et al. [11] and Sancheti et al. [29] We speculated that the extracts from the shell of DL1 may be a therapy for hyperglycemia via inhibiting α-glucosidase and β-galactosidase, possibly due to gallic acid and ellagic acid present within the extract. Consequently, the present study revealed that longan fruit (DL1) shell may be a candidate and beneficial for management of diabetic patients.
CONCLUSIONS
In this research, we found that the shell of Dimocarpus longan var. Fen Ke (DL1) with superior αamylase inhibitory by the contrast with other two species. The longan fruit (DL1) shell also exhibited inhibitory properties against α-glucosidase and β-galactosidase, which may be due to that gallic acid and ellagic acid were identified as the major phenolic compounds. We provide initial evidence of in vitro hypoglycemic activity of LFS. Therefore, LFS may be excellent sources of nutraceutical ingredients and recognized as a potential strategy for management of hyperglycemia.
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